US and Irish firms line up on Pfizer and Allergan's $160bn merger
A host of US and Irish firms are taking the lead on Pfizer's $160bn merger with pharmaceutical rival Allergan.
Skadden Arps Slate Meagher & Flom is representing Pfizer, with a team including M&A partners Paul Schnell, Sean Doyle and Michael Chitwood in New York. Washington tax partner Paul Oosterhuis is working alongside partners Sally Thurston, Steven Matays and Brian Krause in New York, while IP matters are being handled by Resa Schlossberg and Jose Esteves.
US patent litigatio...